— Know what they know.
Not Investment Advice

BJDX NASDAQ

Bluejay Diagnostics, Inc.
1W: -9.2% 1M: -1.5% 3M: -27.9% YTD: -68.1% 1Y: -86.3% 3Y: -100.0%
$0.84
-0.01 (-1.12%)
 
Weekly Expected Move ±16.7%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Medical - Devices · Tech Score Sell · Power 41 · $865642 mcap · 879953 float · 557.94% daily turnover · Short 23% of daily vol

Balance Sheet Trends

Total Assets
$7M +6.9% ▲
5Y CAGR: +36.2%
Total Liabilities
$1M +23.3% ▲
5Y CAGR: -27.5%
Shareholders Equity
$6M +4.3% ▲
Cash & Investments
$5M +20.1% ▲
5Y CAGR: +41.4%
Total Debt
$120K -45.9% ▼
5Y CAGR: -35.2%
Net Debt
-$5M -23.7% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$19M$10M$2M$4M$5M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$19M$10M$2M$4M$5M
Net Receivables$0$0$41K$15K$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$224K-$15K$299K
Total Current Assets$21M$12M$3M$5M$5M
Property, Plant & Equip.$333K$2M$2M$2M$2M
Goodwill & Intangibles$5K$4K$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$21K$31K$29K$35K$8K
Total Non-Current Assets$358K$2M$2M$2M$2M
Total Assets$21M$14M$5M$7M$7M
— Liabilities —
Accounts Payable$296K$636K$491K$145K$214K
Short-Term Debt$0$0$0$113K$100K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$5K$5K$5K$805K
Total Current Liabilities$637K$2M$2M$810K$1M
Long-Term Debt$0$0$0$0$20K
Other Non-Current Liab.$0$16K$12K$9K$5K
Total Non-Current Liabilities$0$340K$202K$118K$25K
Total Liabilities$637K$2M$2M$928K$1M
— Equity —
Common Stock$2K$2K$124$55$60
Retained Earnings-$8M-$17M-$27M-$35M-$42M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$20M$12M$3M$6M$6M
Total Liabilities & Equity$21M$14M$5M$7M$7M
— Key Metrics —
Total Debt$0$493K$353K$222K$120K
Net Debt-$19M-$10M-$2M-$4M-$5M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms